Literature DB >> 2253086

IgE, IgA and IgG antibodies and delayed skin response towards Candida albicans antigens in atopics with and without saprophytic growth.

J Savolainen1, A Koivikko, K Kalimo, E Nieminen, M Viander.   

Abstract

Immunoblotting and RAST were used to analyse IgE, IgA and IgG responses to antigens of Candida albicans. These were compared with the delayed skin response and C. albicans carriage in 40 atopic subjects. The majority of the atopic patients showed a strong IgG and IgA antibody response towards mannan, a carbohydrate, but only occasionally to proteins. Altogether 22 of the 40 patients showed specific IgE towards C. albicans by immunoblotting. The IgE response was mainly towards proteins, particularly to ones with molecular weights of 29 kD and 46 kD, and only in eight out of 22 IgE-positive subjects towards mannan. The IgG and IgA responses to mannan and the total IgE response towards C. albicans assessed by RAST showed an association with C. albicans carriage, whereas the delayed skin response showed an inverse relationship. The immunological parameters characteristic of C. albicans carriage were found to be C. albicans-specific depressed delayed skin response and elevated IgE, IgA and IgG responses. This situation in the atopics presenting such parameters may favour simultaneous sensitization and exposure by colonization. The degree of sensitization may be sufficiently high to produce symptomatic allergy, such as asthma, in some individuals during occasional overgrowth of C. albicans, e.g. due to antibiotic therapy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2253086     DOI: 10.1111/j.1365-2222.1990.tb03148.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  6 in total

1.  Reduced proliferative responses of peripheral blood mononuclear cells specifically to Candida albicans antigen in patients with atopic dermatitis--comparison with their normal reactivity to bacterial superantigens.

Authors:  M Tanaka; S Aiba; K Takahashi; H Tagami
Journal:  Arch Dermatol Res       Date:  1996-08       Impact factor: 3.017

2.  Evidence for the presence of immunoglobulin E antibodies specific to the cell wall phosphomannoproteins of Candida albicans in patients with allergies.

Authors:  T Kanbe; M Morishita; K Ito; K Tomita; K Utsunomiya; A Ishiguro
Journal:  Clin Diagn Lab Immunol       Date:  1996-11

Review 3.  T helper cell dichotomy to Candida albicans: implications for pathology, therapy, and vaccine design.

Authors:  L Romani; E Cenci; A Menacci; F Bistoni; P Puccetti
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

Review 4.  Fungal allergens.

Authors:  W E Horner; A Helbling; J E Salvaggio; S B Lehrer
Journal:  Clin Microbiol Rev       Date:  1995-04       Impact factor: 26.132

Review 5.  Targeting Glycoproteins as a therapeutic strategy for diabetes mellitus and its complications.

Authors:  Rozita Naseri; Seyed Jafar Navabi; Zeinab Samimi; Abhay Prakash Mishra; Manisha Nigam; Harish Chandra; Ahmed Olatunde; Habibu Tijjani; Raquel P Morais-Urano; Mohammad Hosein Farzaei
Journal:  Daru       Date:  2020-01-31       Impact factor: 3.117

6.  Neutralizing antibody to interleukin 4 induces systemic protection and T helper type 1-associated immunity in murine candidiasis.

Authors:  L Romani; A Mencacci; U Grohmann; S Mocci; P Mosci; P Puccetti; F Bistoni
Journal:  J Exp Med       Date:  1992-07-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.